Insight from Pimco's Mohamed El-Erian
Airtime: Tues. Oct. 12 2010 | 8:40 AM ET
Insight on the markets, with Mohamed El-Erian, PIMCO.
Airtime: Tues. Oct. 12 2010 | 8:40 AM ET
Insight on the markets, with Mohamed El-Erian, PIMCO.
A look at how the legendary trader gained his fame.
Mongolian Mining Corp is set to debut on the Hong Kong market today. In this First on CNBC interview, its executive director & chairman Odjargal Jambaljamts, sheds more light on its corporate strategy going forward, with CNBC’s Bernard Lo, Lisa Oake & Sri Jegarajah.
The European Central Bank left interest rates unchanged at 1.0%, as expected Thursday. Ian Stannard from BNP Paribas, Lothar Mentel, CIO of Octopus Investments, and Neil MacKinnon from VTB Capital discussed the outlook.
Dana Telsey, chief research officer at the Telsey Advisory Group, shares her reaction to March chain store sales data.
The March trade gap is at its highest since December 2008. CNBC’s Rick Santelli and Steve Liesman parse the data.
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.